Par reports second-quarter earnings

WOODCLIFF LAKE, N.J. — Par Pharmaceutical had sales of $224.2 million and profits of $9.05 million during second quarter 2011, the drug maker said Wednesday.



These compared with respective sales and second-quarter profits of $255.5 million and $18.4 million in second quarter 2010.



For the first six months of fiscal year 2011, the company had sales of $435.8 million and a loss of $99.9 million, compared with $537 million in sales and profits of $44.7 million during the first six months of 2010.